This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ledford, R. M.
Right arrow Articles by Pevear, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledford, R. M.
Right arrow Articles by Pevear, D. C.

 Previous Article  |  Next Article 

Journal of Virology, April 2004, p. 3663-3674, Vol. 78, No. 7
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.7.3663-3674.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

VP1 Sequencing of All Human Rhinovirus Serotypes: Insights into Genus Phylogeny and Susceptibility to Antiviral Capsid-Binding Compounds

Rebecca M. Ledford, Nitesh R. Patel, Tina M. Demenczuk, Adiba Watanyar, Torsten Herbertz, Marc S. Collett, and Daniel C. Pevear*

ViroPharma, Inc., Exton, Pennsylvania 19341

Received 30 July 2003/ Accepted 25 November 2003

Rhinoviruses are the most common infectious agents of humans. They are the principal etiologic agents of afebrile viral upper-respiratory-tract infections (the common cold). Human rhinoviruses (HRVs) comprise a genus within the family Picornaviridae. There are >100 serotypically distinct members of this genus. In order to better understand their phylogenetic relationship, the nucleotide sequence for the major surface protein of the virus capsid, VP1, was determined for all known HRV serotypes and one untyped isolate (HRV-Hanks). Phylogenetic analysis of deduced amino acid sequence data support previous studies subdividing the genus into two species containing all but one HRV serotype (HRV-87). Seventy-five HRV serotypes and HRV-Hanks belong to species HRV-A, and twenty-five HRV serotypes belong to species HRV-B. Located within VP1 is a hydrophobic pocket into which small-molecule antiviral compounds such as pleconaril bind and inhibit functions associated with the virus capsid. Analyses of the amino acids that constitute this pocket indicate that the sequence correlates strongly with virus susceptibility to pleconaril inhibition. Further, amino acid changes observed in reduced susceptibility variant viruses recovered from patients enrolled in clinical trials with pleconaril were distinct from those that confer natural phenotypic resistance to the drug. These observations suggest that it is possible to differentiate rhinoviruses naturally resistant to capsid function inhibitors from those that emerge from susceptible virus populations as a result of antiviral drug selection pressure based on sequence analysis of the drug-binding pocket.

* Corresponding author. Mailing address: ViroPharma, Inc., 405 Eagleview Blvd., Exton, PA 19341. Phone: (610) 321-6210. Fax: (610) 458-7380. E-mail: dpevear{at}comcast.net.

Journal of Virology, April 2004, p. 3663-3674, Vol. 78, No. 7
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.7.3663-3674.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wisdom, A., Leitch, E. C. M., Gaunt, E., Harvala, H., Simmonds, P. (2009). Screening Respiratory Samples for Detection of Human Rhinoviruses (HRVs) and Enteroviruses: Comprehensive VP4-VP2 Typing Reveals High Incidence and Genetic Diversity of HRV Species C. J. Clin. Microbiol. 47: 3958-3967 [Abstract] [Full Text]  
  • Katpally, U., Fu, T.-M., Freed, D. C., Casimiro, D. R., Smith, T. J. (2009). Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic Neutralization. J. Virol. 83: 7040-7048 [Abstract] [Full Text]  
  • Blomqvist, S., Savolainen-Kopra, C., Paananen, A., Hovi, T., Roivainen, M. (2009). Molecular characterization of human rhinovirus field strains isolated during surveillance of enteroviruses. J. Gen. Virol. 90: 1371-1381 [Abstract] [Full Text]  
  • Lewis-Rogers, N., Bendall, M. L., Crandall, K. A. (2009). Phylogenetic Relationships and Molecular Adaptation Dynamics of Human Rhinoviruses. Mol Biol Evol 26: 969-981 [Abstract] [Full Text]  
  • Palmenberg, A. C., Spiro, D., Kuzmickas, R., Wang, S., Djikeng, A., Rathe, J. A., Fraser-Liggett, C. M., Liggett, S. B. (2009). Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution. Science 324: 55-59 [Abstract] [Full Text]  
  • Kiang, D., Kalra, I., Yagi, S., Louie, J. K., Boushey, H., Boothby, J., Schnurr, D. P. (2008). Assay for 5' Noncoding Region Analysis of All Human Rhinovirus Prototype Strains. J. Clin. Microbiol. 46: 3736-3745 [Abstract] [Full Text]  
  • Cordey, S., Gerlach, D., Junier, T., Zdobnov, E. M., Kaiser, L., Tapparel, C. (2008). The cis-acting replication elements define human enterovirus and rhinovirus species. RNA 14: 1568-1578 [Abstract] [Full Text]  
  • Lu, X., Holloway, B., Dare, R. K., Kuypers, J., Yagi, S., Williams, J. V., Hall, C. B., Erdman, D. D. (2008). Real-Time Reverse Transcription-PCR Assay for Comprehensive Detection of Human Rhinoviruses. J. Clin. Microbiol. 46: 533-539 [Abstract] [Full Text]  
  • Binford, S. L., Weady, P. T., Maldonado, F., Brothers, M. A., Matthews, D. A., Patick, A. K. (2007). In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C Protease. Antimicrob. Agents Chemother. 51: 4366-4373 [Abstract] [Full Text]  
  • Lau, S. K. P., Yip, C. C. Y., Tsoi, H.-w., Lee, R. A., So, L.-y., Lau, Y.-l., Chan, K.-h., Woo, P. C. Y., Yuen, K.-y. (2007). Clinical Features and Complete Genome Characterization of a Distinct Human Rhinovirus (HRV) Genetic Cluster, Probably Representing a Previously Undetected HRV Species, HRV-C, Associated with Acute Respiratory Illness in Children. J. Clin. Microbiol. 45: 3655-3664 [Abstract] [Full Text]  
  • Khan, A. G., Pichler, J., Rosemann, A., Blaas, D. (2007). Human Rhinovirus Type 54 Infection via Heparan Sulfate Is Less Efficient and Strictly Dependent on Low Endosomal pH. J. Virol. 81: 4625-4632 [Abstract] [Full Text]  
  • Kaiser, L., Aubert, J.-D., Pache, J.-C., Deffernez, C., Rochat, T., Garbino, J., Wunderli, W., Meylan, P., Yerly, S., Perrin, L., Letovanec, I., Nicod, L., Tapparel, C., Soccal, P. M. (2006). Chronic Rhinoviral Infection in Lung Transplant Recipients. Am. J. Respir. Crit. Care Med. 174: 1392-1399 [Abstract] [Full Text]  
  • Laine, P., Blomqvist, S., Savolainen, C., Andries, K., Hovi, T. (2006). Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains. J. Gen. Virol. 87: 129-138 [Abstract] [Full Text]  
  • Nizet, S., Wruss, J., Landstetter, N., Snyers, L., Blaas, D. (2005). A Mutation in the First Ligand-Binding Repeat of the Human Very-Low-Density Lipoprotein Receptor Results in High-Affinity Binding of the Single V1 Module to Human Rhinovirus 2. J. Virol. 79: 14730-14736 [Abstract] [Full Text]  
  • Pevear, D. C., Hayden, F. G., Demenczuk, T. M., Barone, L. R., McKinlay, M. A., Collett, M. S. (2005). Relationship of Pleconaril Susceptibility and Clinical Outcomes in Treatment of Common Colds Caused by Rhinoviruses. Antimicrob. Agents Chemother. 49: 4492-4499 [Abstract] [Full Text]  
  • Schmidtke, M., Hammerschmidt, E., Schuler, S., Zell, R., Birch-Hirschfeld, E., Makarov, V. A., Riabova, O. B., Wutzler, P. (2005). Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J Antimicrob Chemother 56: 648-656 [Abstract] [Full Text]  
  • Vlasak, M., Roivainen, M., Reithmayer, M., Goesler, I., Laine, P., Snyers, L., Hovi, T., Blaas, D. (2005). The Minor Receptor Group of Human Rhinovirus (HRV) Includes HRV23 and HRV25, but the Presence of a Lysine in the VP1 HI Loop Is Not Sufficient for Receptor Binding. J. Virol. 79: 7389-7395 [Abstract] [Full Text]  
  • Vlasak, M., Goesler, I., Blaas, D. (2005). Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment. J. Virol. 79: 5963-5970 [Abstract] [Full Text]  
  • Makarov, V. A., Riabova, O. B., Granik, V. G., Wutzler, P., Schmidtke, M. (2005). Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication. J Antimicrob Chemother 55: 483-488 [Abstract] [Full Text]  
  • Laine, P., Savolainen, C., Blomqvist, S., Hovi, T. (2005). Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J. Gen. Virol. 86: 697-706 [Abstract] [Full Text]  
  • Binford, S. L., Maldonado, F., Brothers, M. A., Weady, P. T., Zalman, L. S., Meador, J. W. III, Matthews, D. A., Patick, A. K. (2005). Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor. Antimicrob. Agents Chemother. 49: 619-626 [Abstract] [Full Text]  
  • Zhang, Y., Simpson, A. A., Ledford, R. M., Bator, C. M., Chakravarty, S., Skochko, G. A., Demenczuk, T. M., Watanyar, A., Pevear, D. C., Rossmann, M. G. (2004). Structural and Virological Studies of the Stages of Virus Replication That Are Affected by Antirhinovirus Compounds. J. Virol. 78: 11061-11069 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»